EUVIMEDEUVIMED entdecken
Crossref

A Clinical Decision Tree to Support Keratoconus Patients Considering Corneal Cross-Linking Combined with Refractive Treatment

Katja Iselin, Lucas Bachmann, Philipp Baenninger, Frantisek Sanak, Claude Kaufmann

Klinische Monatsblätter für Augenheilkunde · 01.04.2023 · 240 (04) · 379-384

DOI: 10.1055/a-2017-5203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2023. Verfasst von Katja Iselin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Ophthalmology, Lucerne Cantonal Hospital, Lucerne, Switzerland. Hauptthemen laut MEDLINE: Photochemotherapy, Keratoconus. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To develop a fast and frugal decision tree to identify keratoconus patients most likely to benefit visually from the combination of corneal cross-linking (CXL) with topography-guided photorefractive keratectomy (“CXL plus”). Patients and Methods The outcome of interest was an improvement in uncorrected distance visual acuity (UDVA) by at least two lines at the 12-month follow-up. Preoperative and 12-month follow-up data from patients who received CXL plus (n = 96) and CXL only (n = 96) were used in a recursive partitioning approach to construct a frugal tree with three variables (corneal thickness [>/< 430 um], patient interest in CXL plus [yes/no], and tomographic cylinder [ 3 D]). In addition, we estimated the probability of the outcome from a multivariate logistic regression model for each combination of variables used in the decision tree.

Results

In the complete sample, 101/192 (52.6%) patients improved by at least two lines at the 12-month follow-up. Patients affirmative in all three answers had a 75.6% (34/45) probability of gaining at least two lines of improvement in UDVA by CXL plus. The statistical model estimated a 66.0% probability for a successful outcome.

Conclusion

A fast and frugal tree consisting of three variables can be used to select a patient group with a high likelihood to benefit from CXL plus. The tree is useful in the preoperative counseling of keratoconus patients contemplating the CXL plus option, an intervention that is not fully covered by many health insurances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyKeratoconusHumansCorneal Cross-LinkingPhotosensitizing AgentsRiboflavinLasers, ExcimerCombined Modality TherapyUltraviolet RaysCorneal StromaCorneal TopographyCross-Linking ReagentsDecision Trees

Substanzen

Photosensitizing AgentsRiboflavinCross-Linking Reagents

Autor:innen und Institutionen

  • Dept. of Ophthalmology, Lucerne Cantonal Hospital, Lucerne, Switzerland.
  • Medignition Healthcare Innovations, Zurich, Switzerland.

Zitieren

APA

Iselin, K., Bachmann, L., Baenninger, P., Sanak, F., & Kaufmann, C. (2023). A Clinical Decision Tree to Support Keratoconus Patients Considering Corneal Cross-Linking Combined with Refractive Treatment. Klinische Monatsblätter für Augenheilkunde, 240(04), 379-384. https://doi.org/10.1055/a-2017-5203

Vancouver

Iselin K, Bachmann L, Baenninger P, Sanak F, Kaufmann C. A Clinical Decision Tree to Support Keratoconus Patients Considering Corneal Cross-Linking Combined with Refractive Treatment. Klinische Monatsblätter für Augenheilkunde. 2023;240(04):379-384. doi:10.1055/a-2017-5203

BibTeX
@article{Iselin2023,
  author = {Iselin, Katja and Bachmann, Lucas and Baenninger, Philipp and Sanak, Frantisek and Kaufmann, Claude},
  title = {A Clinical Decision Tree to Support Keratoconus Patients Considering Corneal Cross-Linking Combined with Refractive Treatment},
  journal = {Klinische Monatsblätter für Augenheilkunde},
  year = {2023},
  volume = {240},
  number = {04},
  pages = {379--384},
  doi = {10.1055/a-2017-5203}
}
Kostenlos starten →